首页 › 基金 › Creek Drive Management Group LLC › RNA
Creek Drive Management Group LLC 对 RNA 的持仓历史
ATRIUM THERAPEUTICS INC · 医疗保健
Creek Drive Management Group LLC 在 Q2 2026 的 13F 申报中披露持有 RNA(ATRIUM THERAPEUTICS INC)127,600 股,市值约 US$1.7M,约占其申报组合的 0.98%,在其申报持仓中市值排名第 28 位。 Creek Drive Management Group LLC 最近 2 个申报季度中有 2 个季度披露了 RNA 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Creek Drive Management Group LLC 对 RNA 的持仓演变
Creek Drive Management Group LLC 于 Q1 2026 首次披露 RNA 持仓:120,000 股(约 US$1.6M)。 该持仓在 Q2 2026 达到峰值 127,600 股,市值约 US$1.7M。 在 2 次申报中,Creek Drive Management Group LLC 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 127,600 股、市值约 US$1.7M,环比增持 7,600 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 120.00K | $1.60M | 新进 |
| Q2 2026 | 127.60K | $1.72M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RNA 与 13F 数据
RNA(ATRIUM THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 116 只申报持有 RNA,申报仓位最大的包括:Sessa Capital IM, L.P. (US$20.2M), CRCM LP (US$8.6M), TIG Advisors, LLC (US$7.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RNA 的基金
- Sessa Capital IM, L.P. 1.50M 股 · $20.18M · Q2 2026
- CRCM LP 641.54K 股 · $8.63M · Q2 2026
- TIG Advisors, LLC 561.53K 股 · $7.55M · Q2 2026
- Arbiter Partners Capital Management LLC 261.29K 股 · $3.51M · Q2 2026
- Slotnik Capital, LLC 237.64K 股 · $3.20M · Q2 2026
- NEXPOINT ASSET MANAGEMENT, L.P. 150.03K 股 · $2.02M · Q2 2026
- Bracebridge Capital, LLC 139.24K 股 · $1.87M · Q2 2026
- Yakira Capital Management, Inc. 133.05K 股 · $1.79M · Q2 2026
- Athos Capital Ltd 107.97K 股 · $1.45M · Q2 2026
- Marble Bar Asset Management LLP 103.85K 股 · $1.40M · Q2 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 43.76K 股 · $588.54K · Q2 2026
- Trium Capital LLP 58.38K 股 · $483.40K · Q3 2026
更多关于 Creek Drive Management Group LLC
常见问题
How long has Creek Drive Management Group LLC held RNA?
Creek Drive Management Group LLC has disclosed RNA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Creek Drive Management Group LLC's current position in RNA?
As of Q2 2026, Creek Drive Management Group LLC holds 127.60K shares of RNA (ATRIUM THERAPEUTICS INC), valued at $1.72M, representing 0.98% of its reported portfolio and ranking #28.
Has Creek Drive Management Group LLC been buying or selling RNA?
In the latest 13F filing (Q2 2026), Creek Drive Management Group LLC increased its position in RNA. The position peaked in Q2 2026 at 127.60K shares.
Which other funds hold RNA?
Other major institutional holders of RNA include Sessa Capital IM, L.P., CRCM LP, TIG Advisors, LLC, among 116 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.